-
Anthera Pharmaceuticals (NASDAQ:ANTH) stock analysis and forecast
Anthera Pharmaceuticals (NASDAQ:ANTH) is a bio-pharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders. Recently they have been performing clinical trials using the drug “Blisibimod” on Lupus patients. Blisibimod (also known as A-623, formerly AMG 623) is a selective antagonist of B-cell activating factor (BAFF, also known…